Delivery Order SPE2DB20D2104-SPE2DB23FR63F
Award Date 12/31/22
Potential Completion Date 1/3/23
Potential Value $7.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,991.66, is for the delivery of 4,566,405,648 units of Ondansetron HCl 4 mg Tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of November 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,090,414 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $47,037.51 and a completion date of January 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,985,711 tablets of 8 mg Ondansetron HCl, a medication used to treat nausea and vomiting. The contract has a firm fixed price of $14,206.08 and a completion date of April 22, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,093,289 tablets of Ondansetron HCL 4 MG, a medication used to treat nausea and vomiting. The contract has a ceiling value of $17,229.82 and a completion date of December 14, 2023. This award is not designated as a set-aside contract. The contract is a Firm...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,222,794 units of Ondansetron HCL 4 mg tablets, a medication commonly used to prevent nausea and vomiting. The contract has a total ceiling value of $14,687.87 and runs through February 11, 2025. This contract is not designated as a set-aside contract. AmerisourceBergen holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,560,954,709 units of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $19,195.17 and a completion date of May 17, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,563,866,919 units of Ondansetron HCL 8 mg tablets, a medication commonly used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $5,111.82 and a period of performance through March 6, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,174.55 contract is for the delivery of 500 units of 8 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,566,340,622 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price of $7,873.25 and a period of performance through November 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,698.36 firm fixed-price delivery order is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of July 8, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...